Pages that link to "Q34578479"
Jump to navigation
Jump to search
The following pages link to Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). (Q34578479):
Displaying 50 items.
- Hereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies (Q28972400) (← links)
- Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency (Q33560367) (← links)
- Recurrent angioedema and the threat of asphyxiation (Q33946601) (← links)
- Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group (Q34029593) (← links)
- Factor XII mutations, estrogen-dependent inherited angioedema, and related conditions (Q34060658) (← links)
- Management of acute attacks of hereditary angioedema: potential role of icatibant (Q34139106) (← links)
- Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment (Q34579883) (← links)
- Hereditary angioedema: a current state-of-the-art review, VIII: current status of emerging therapies (Q34741437) (← links)
- Brazilian guidelines for the diagnosis and treatment of hereditary angioedema (Q35188409) (← links)
- Hereditary Angioedema and Gastrointestinal Complications: An Extensive Review of the Literature (Q35961086) (← links)
- An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II. (Q36307805) (← links)
- Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema (Q36326043) (← links)
- Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research project (Q36373700) (← links)
- Role of the bradykinin B2 receptor in a rat model of local heart irradiation. (Q36552117) (← links)
- New treatments addressing the pathophysiology of hereditary angioedema (Q36642688) (← links)
- Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain. (Q36646147) (← links)
- Using a bradykinin blocker in ACE inhibitor-associated angioedema in the emergency department (Q36703230) (← links)
- Successful treatment of acute hereditary angioedema attacks with self-administered icatibant in patients with venous access problems (Q36820332) (← links)
- Hereditary angioedema: epidemiology, management, and role of icatibant (Q36825274) (← links)
- WAO Guideline for the Management of Hereditary Angioedema (Q36834816) (← links)
- Oestrogen-dependent hereditary angio-oedema with normal C1 inhibitor: description of six new cases and review of pathogenic mechanisms and treatment (Q37028371) (← links)
- Treatment of hereditary angioedema with plasma-derived C1 inhibitor (Q37052806) (← links)
- Hereditary angiodema: a current state-of-the-art review, VI: novel therapies for hereditary angioedema (Q37065133) (← links)
- The kallikrein-kinin system in diabetic retinopathy: lessons for the kidney (Q37084085) (← links)
- Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability (Q37161400) (← links)
- Current and emerging management options for hereditary angioedema in the US. (Q37354117) (← links)
- Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema (Q37359802) (← links)
- Clinical Immunology Review Series: An approach to the patient with angio-oedema (Q37394385) (← links)
- When is prophylaxis for hereditary angioedema necessary? (Q37506359) (← links)
- Analgesic targets: today and tomorrow (Q37511848) (← links)
- Coughing precipitated by Bordetella pertussis infection (Q37638384) (← links)
- Ecallantide: its pharmacology, pharmacokinetics, clinical efficacy and tolerability (Q37729036) (← links)
- Enzymatic pathways in the pathogenesis of hereditary angioedema: The role of C1 inhibitor therapy (Q37796385) (← links)
- Therapeutic approaches in hereditary angioedema. (Q37833531) (← links)
- Conestat alfa for the treatment of angioedema attacks (Q37900837) (← links)
- New topics in bradykinin research. (Q37920922) (← links)
- Human pasteurized C1-inhibitor concentrate for the treatment of hereditary angioedema due to C1-inhibitor deficiency (Q37947670) (← links)
- The Kallikrein/Kinin System in Ocular Function (Q37963919) (← links)
- International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency (Q37971209) (← links)
- Current management options for hereditary angioedema (Q38021414) (← links)
- Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems (Q38042696) (← links)
- Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic (Q38058560) (← links)
- Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema (Q38196412) (← links)
- Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors (Q38217456) (← links)
- Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study (Q38443205) (← links)
- Current treatment options for hereditary angioedema due to C1 inhibitor deficiency (Q38619062) (← links)
- Icatibant as acute treatment for hereditary angioedema in adults. (Q38819740) (← links)
- A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE). (Q38840241) (← links)
- The Story of Angioedema: from Quincke to Bradykinin (Q38855032) (← links)
- Factor XII gene missense mutation Thr328Lys in an Arab family with hereditary angioedema type III (Q38887662) (← links)